InteLearn ™

Licensed exclusively from Duke-NUS to MEDNIVA for the global healthcare industry

  • Patent Title: "Method For Applying Scientific Research On Brain Learning To Optimize Individual Learning Environments" (patent pending; patent application number 10201505840U)
  • Applies cognitive science and multiple proven learning effects to optimize learning in customized environments

InteLearn™, licensed exclusively from Duke-NUS to MEDNIVA for the global healthcare industry, is a patent-pending* learning technology that applies cognitive science to optimize learning. InteLearn™ applies multiple proven learning effects to optimize learning in customized environments. These effects include:

 

Brain Priming Effect:customized pre-testing to increase retention Application & Relevance: doing relevant, customized activities vs. hearing about irrelevant content Peer Learning: more effective, active group learning customized by stakeholder Adult Attention Span: 6-10 minute modular content customized by stakeholder Optimal Spacing: longer spaced learning = longer retention Recall:customized testing (forced recall), which is 40% more effective than re-reading

Science-Led Learning for a Science-Led Industry

MEDNIVA translates succesful outcomes from Duke-NUS Medical School (Singapore) and Duke University School of Medicine (U.S.A.) to global healthcare industry learning needs.

Copyright © MEDNIVA - All rights reserved.
Terms of usePrivacy